Literature DB >> 19546037

The role of protein synthesis in cell cycling and cancer.

Shai White-Gilbertson1, David T Kurtz, Christina Voelkel-Johnson.   

Abstract

Cell cycling and protein synthesis are both key physiological tasks for cancer cells. Here we present a model for how the elongation phase of protein synthesis, governed by elongation factor 2 and elongation factor 2 kinase, both modulates and responds to cell cycling. Within this framework we also discuss survivin, a protein with both pro-mitotic and anti-apoptotic roles whose persistence in the cell is tied to protein synthesis due to its short half-life. Finally, we provide a brief overview of efforts of cancer researchers to target EF2 and EF2 kinase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546037      PMCID: PMC2784195          DOI: 10.1016/j.molonc.2009.05.003

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  46 in total

1.  Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.

Authors:  J Yang; J M Yang; M Iannone; W J Shih; Y Lin; W N Hait
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

2.  Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase.

Authors:  Sonia Arora; Jin-Ming Yang; William N Hait
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

3.  Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2.

Authors:  Shai J White; Laura M Kasman; Margaret M Kelly; Ping Lu; Laura Spruill; Paul J McDermott; Christina Voelkel-Johnson
Journal:  Free Radic Biol Med       Date:  2007-07-03       Impact factor: 7.376

4.  Elongation factor-2 kinase regulates autophagy in human glioblastoma cells.

Authors:  Hao Wu; Jin-Ming Yang; Shengkan Jin; Haiyan Zhang; William N Hait
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

5.  cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner.

Authors:  Ewan M Smith; Christopher G Proud
Journal:  EMBO J       Date:  2008-03-13       Impact factor: 11.598

6.  Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM.

Authors:  C Desdouets; G Matesic; C A Molina; N S Foulkes; P Sassone-Corsi; C Brechot; J Sobczak-Thepot
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

7.  Mitotic catastrophe cell death induced by heat shock protein 90 inhibitor in BRCA1-deficient breast cancer cell lines.

Authors:  Magdalena Zajac; Maria Victoria Moneo; Amancio Carnero; Javier Benitez; Beatriz Martínez-Delgado
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

Review 8.  The role of protein synthesis in cell cycling and cancer.

Authors:  Shai White-Gilbertson; David T Kurtz; Christina Voelkel-Johnson
Journal:  Mol Oncol       Date:  2009-06-11       Impact factor: 6.603

Review 9.  Phosphorylation of elongation factor 2: a key mechanism regulating gene expression in vertebrates.

Authors:  A G Ryazanov; A S Spirin
Journal:  New Biol       Date:  1990-10

10.  Identification of G2/M targets for the MAP kinase pathway by functional proteomics.

Authors:  Elisabeth C Roberts; Kasey Hammond; Abdulmaged M Traish; Katheryn A Resing; Natalie G Ahn
Journal:  Proteomics       Date:  2006-08       Impact factor: 3.984

View more
  31 in total

1.  Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells.

Authors:  Li Zhang; Yi Zhang; Xiao-yuan Liu; Zheng-hong Qin; Jin-ming Yang
Journal:  Acta Pharmacol Sin       Date:  2011-01-31       Impact factor: 6.150

2.  Effect of linear alkylbenzene sulfonate (LAS) on human intestinal Caco-2 cells at non cytotoxic concentrations.

Authors:  Mohamed Bradai; Junkyu Han; Abdelfatteh El Omri; Naoyuki Funamizu; Sami Sayadi; Hiroko Isoda
Journal:  Cytotechnology       Date:  2015-05-22       Impact factor: 2.058

3.  Mammalian cell growth dynamics in mitosis.

Authors:  Teemu P Miettinen; Joon Ho Kang; Lucy F Yang; Scott R Manalis
Journal:  Elife       Date:  2019-05-07       Impact factor: 8.140

4.  Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.

Authors:  Arron Sikka; Manjinder Kaur; Chapla Agarwal; Gagan Deep; Rajesh Agarwal
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

5.  Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer.

Authors:  X Wen; Z-Q Lin; B Liu; Y-Q Wei
Journal:  Cell Prolif       Date:  2012-03-20       Impact factor: 6.831

6.  Molecular control of the amount, subcellular location, and activity state of translation elongation factor 2 in neurons experiencing stress.

Authors:  Sandro Argüelles; Simonetta Camandola; Emmette R Hutchison; Roy G Cutler; Antonio Ayala; Mark P Mattson
Journal:  Free Radic Biol Med       Date:  2013-03-29       Impact factor: 7.376

7.  High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions.

Authors:  Marsilius Mues; Laila Karra; Damia Romero-Moya; Anica Wandler; Matthew J Hangauer; Olga Ksionda; Yvonne Thus; Marthe Lindenbergh; Kevin Shannon; Michael T McManus; Jeroen P Roose
Journal:  Cell Rep       Date:  2019-04-09       Impact factor: 9.423

8.  Translational control of cyclins.

Authors:  Woan-Yuh Tarn; Ming-Chih Lai
Journal:  Cell Div       Date:  2011-02-11       Impact factor: 5.130

9.  Tumor suppressor p16(INK4a) inhibits cancer cell growth by downregulating eEF1A2 through a direct interaction.

Authors:  Mee-Hyun Lee; Bu Young Choi; Yong-Yeon Cho; Sung-Young Lee; Zunnan Huang; Joydeb Kumar Kundu; Myoung Ok Kim; Dong Joon Kim; Ann M Bode; Young-Joon Surh; Zigang Dong
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

10.  Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival.

Authors:  Yi Liao; Hsueh-Ping Chu; Zhixian Hu; Jason J Merkin; Jianmin Chen; Zuguo Liu; Kurt Degenhardt; Eileen White; Alexey G Ryazanov
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.